| Literature DB >> 33920192 |
Inês Neves1, Maria D Auxtero1.
Abstract
Extemporaneous suspensions are often marketed with several administration devices that can be freely used by patients/caregivers. The homogeneity of suspensions requires shaking before use. Hence, it is crucial to assess the precision of all devices and the users' awareness of the shaking procedure. This study was conducted at University Institute Egas Moniz with 40 pharmacy students who were asked to measure 2.5 and 5 mL of two extemporaneous azithromycin suspensions. Formulation A is marketed with a double-dosing spoon and oral syringe, whereas B includes a transparent dosing spoon. Both have a reconstitution cup. The user's preference for administration devices, the degree of compliance with the 'shake before use' instruction and the accuracy of the manipulation were assessed. The double-dosing spoon was the preferred device. The "shake before use" instruction was overlooked by most volunteers. The average measured volumes obtained with the double-dosing spoon were significantly different from the ones obtained with the oral syringe (p < 0.001) and significantly lower than the reference dose (p < 0.001). The oral syringe originates significantly higher values than the reference dose (p < 0.001). The dosing spoons values were significantly different from each other (p < 0.001). Liquid medicines containing several administration devices may be a challenge since they are nonequivalent.Entities:
Keywords: administration devices; drug administration error; extemporaneous suspensions; pediatrics
Year: 2021 PMID: 33920192 PMCID: PMC8068927 DOI: 10.3390/pharmaceutics13040528
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.321
Characteristics of volunteers.
| Volunteer Characteristics | Number (%) |
|---|---|
| Gender | |
| Female | 32 (80%) |
| Male | 8 (20%) |
| College year | |
| First year | 5 (12.5%) |
| Second year | 9 (22.5%) |
| Third year | 11 (27.5%) |
| Fourth year | 8 (20%) |
| Fifth year | 7 (17.5%) |
| Eyesight problems | |
| Myopia | 11 (27.5%) |
| Stigma | 5 (12.5%) |
| Myopia and Stigma | 4 (10%) |
| Hyperopia | 1 (2.5%) |
| None | 19 (47.5%) |
| Vision aids | |
| Glasses (Group 2) | 6 (15%) |
| Lenses (Group 2) | 6 (15%) |
| None (with eyesight problems) (Group 1) | 9 (22.5%) |
| None (no eyesight problems) (Group 2) | 19 (47.5%) |
Figure 1Reconstitution cup (volume marks = 8 and 16 mL), double-dosing spoon (volume = 2.5 and 5 mL) and oral syringe (volume = 0–5 mL) of the antibiotic A.
Figure 2Transparent dosing spoon used for antibiotic B (volume marks at 2.5 and 5 mL).
Reference weights and respective standard deviation (SD) (n = 3), for the average value of volumes 2.5 and 5 mL of antibiotic A and antibiotic B.
| Formulation | Average Weight (±SD) (g) |
|---|---|
| Antibiotic A | |
| Volume 2.5 mL (small end of the double spoon) | 3.18 (±0.01) |
| Volume 5 mL (large end of the double spoon) | 6.31 (±0.03) |
| Antibiotic B | |
| Volume 2.5 mL (lower mark of the transparent spoon) | 3.23 (±0.01) |
| Volume 5 mL (upper mark of the transparent spoon) | 6.35 (±0.06) |
Figure 3Administration devices selected as the first choice for antibiotic A administration.
Average weight (n = 40), standard deviation (SD) and 95% confidence interval (95% CI) for 2.5 and 5 mL of antibiotic A, measured with a double-dosing spoon and oral syringe.
| Measured Volume | Average Weight | CI 95% |
|
|---|---|---|---|
| 2.5 mL | |||
| Small end of the double-dosing spoon | 2.3 (±0.4) | (2.1–2.4) | <0.001 |
| Oral syringe | 3.3 (±0.1) | (3.3–3.3) | |
| 5 mL | |||
| Large end of the double-dosing spoon | 5.0 (±0.7) | (4.8–5.2) | <0.001 |
| Oral syringe | 6.5 (±0.2) | (6.4–6.5) |
1 Student t-test for paired samples.
Average weight (n = 40), standard deviation (SD) and 95% confidence interval (95% CI) for 2.5 and 5 mL of antibiotic A, measured with double-dosing spoon and B, measured with transparent dosing spoon.
| Measured Volume | Average Weight | CI 95% |
|
|---|---|---|---|
| 2.5 mL | |||
| Small end of the double-dosing spoon | 2.3 (±0.4) | (2.1–2.4) | <0.001 |
| Transparent dosing spoon | 3.4 (±0.4) | (3.3–3.6) | |
| 5 mL | |||
| Large end of the double-dosing spoon | 5.0 (±0.7) | (4.8–5.2) | <0.001 |
| Transparent dosing spoon | 7.6 (±1.1) | (7.2–7.9) |
1 Student t-test for paired samples.
Figure 4Percentage of deviation from the reference dose, using different administration devices.
Figure 5Assessment of compliance with “Shake before use” instruction for antibiotic A.
Figure 6Assessment of compliance with “Shake before use” instruction for antibiotic B.
Figure 7Comparison of design between the double-dosing spoon (under-dosing) and the transparent dosing spoon (overdosing). ((A) = With rim on periphery and Handle; (B) = Without rim on periphery).